Recent 8-K filings for ADIA
Highest-materiality recent filing
ADIA Med sues Tydus Richards and 12 others to quiet title in 29,059,792 shares, 30.78% of common
- ADIA Med filed a verified complaint September 28, 2026 in Seminole County, Florida Circuit Court, Case No. 2026CA002155, against Tydus Richards and 12 other claimants.
- The action seeks to quiet title in 29,059,792 shares, or 30.78% of issued and outstanding non-preferred common stock, valued at $3,487,175.04 at the August 13, 2026 close.
-
Adia Med sells 7% of Adia Labs LLC to CEO Larry Powalisz for $350,000 cash in related-party deal
Adia Med sold 7 of 100 units in subsidiary Adia Labs LLC to CEO Larry Powalisz for $350,000 cash, or $50,000 per unit, per the Oct 13, 2026 agreement.
-
Adia Med repays CEO Larry Powalisz's $1M related-party credit line in full for $934,970.94
On October 9, 2026 Adia Med fully repaid and discharged its unsecured revolving line of credit from CEO Larry Powalisz, originally dated June 30, 2024.
-
Adia Med sold 30 of 100 units in Adia Labs LLC (30%) to Live Oak Health LLC d/b/a QCM Biologics at $50,000 per unit, or $1,500,000 total, closing September 30, 2026.
-
ADIA Med sues Tydus Richards and 12 others to quiet title in 29,059,792 shares, 30.78% of common
ADIA Med filed a verified complaint September 28, 2026 in Seminole County, Florida Circuit Court, Case No. 2026CA002155, against Tydus Richards and 12 other claimants.
-
Adia Nutrition engages Lucosky Brookman for NASDAQ uplist and bridge financing
Engagement letter dated Aug 14, 2026; fixed fee $150,000 for uplist and bridge financing services.
-
Adia Nutrition changes name to Adia Med, Inc.; ticker ADIA unchanged
Corporate name changed from Adia Nutrition, Inc. to Adia Med, Inc., effective June 2, 2026.
Materiality & sentiment trend
Max materiality 0.72 · Median 0.35 · Most common event m_and_a